Fairvalue-Calculator Fairvalue-Calculator
EN DE

Bio Plus Co (099430) Fair Value & Analysis

Healthcare · KR · Market cap 279B KRW

Price4,285 KRW
Fair Value4,144 KRW
Upside-3.3%
Quality85/100
Evidence: Medium Range 3,108 KRW – 5,180 KRW

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Bio Plus Co (099430) currently trades at 4,285 KRW, while our model-based Fair Value estimate is 4,144 KRW — implying the stock looks roughly 3.3% overvalued today. We read business quality at 85/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Bio Plus Co., Ltd engages in the research and development, production, and sale of bio products in South Korea. It offers dermal fillers under the SkinPlus " Hyal, Bio+ Dew, HyalDew, DeneB Classic, Stilea, and 3-Senses brand names. The company also provides medical products, including InterBlock, an absorbable anti-adhesion barrier; Synofil, a synovial fluid replacement; and Blad-Care, a solution to temporarily improve cystitis symptoms. In addition, it offers mesotherapy products, such as skin rejuvenation products under the Kiara Reju name; Slim Slimmer, a lipolysis solution; LumiDew, a whitening solution; JuveniHill, an anti-wrinkle solution; and hair scalp care, hair treatment, hair nutrition solutions under the BelloHa and BellaChe names, as well as cosmetics comprising heparinoid essence, EGF ball, and skin care gel under the La Bella name. The company was founded in 2003 and is based in Seongnam-si, South Korea.

Open the full interactive analysis →

Similar stocks

Intuitive Surgical, Inc (ISRG) -62% EssilorLuxottica Société anonyme (ESLOF) -34% HOYA Corporation (HOCPY) -42% Medline Inc (MDLN) -15% Becton, Dickinson and Company (BDX) -22% Alcon Inc (ALC) -44%

Frequently asked questions

Is Bio Plus Co (099430) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 4,144 KRW versus a price of 4,285 KRW — about −3% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 099430?
Our 21-model fair value for Bio Plus Co is 4,144 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 4,285 KRW.
What is the quality score of 099430?
Bio Plus Co has a Quality Score of 85/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.